GILD
Price:
$91.69
Market Cap:
$114.15B
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an ora...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1992-01-22
Stock Exchange
NASDAQ
Ticker
GILD
According to Gilead Sciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.14. This represents a change of -8.98% compared to the average of 1.26 of the last 4 quarters.
The mean historical Current Ratio of Gilead Sciences, Inc. over the last ten years is 2.64. The current 1.14 Current Ratio has changed 4.23% with respect to the historical average. Over the past ten years (40 quarters), GILD's Current Ratio was at its highest in in the June 2017 quarter at 5.00. The Current Ratio was at its lowest in in the March 2024 quarter at 1.08.
Average
2.64
Median
3.19
Minimum
1.30
Maximum
4.17
Discovering the peaks and valleys of Gilead Sciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 197.06%
Maximum Annual Current Ratio = 4.17
Minimum Annual Increase = -56.99%
Minimum Annual Current Ratio = 1.30
Year | Current Ratio | Change |
---|---|---|
2023 | 1.46 | 7.65% |
2022 | 1.36 | 4.49% |
2021 | 1.30 | -6.55% |
2020 | 1.39 | -56.99% |
2019 | 3.23 | -4.02% |
2018 | 3.36 | -5.39% |
2017 | 3.55 | -14.87% |
2016 | 4.17 | 21.37% |
2015 | 3.44 | 8.87% |
2014 | 3.16 | 197.06% |
The current Current Ratio of Gilead Sciences, Inc. (GILD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.37
5-year avg
1.74
10-year avg
2.64
Gilead Sciences, Inc.’s Current Ratio is less than Amgen Inc. (1.32), less than Merck & Co., Inc. (1.47), greater than AbbVie Inc. (0.31), greater than Johnson & Johnson (1.03), less than Bristol-Myers Squibb Company (1.24), greater than Pfizer Inc. (1.00), less than Eli Lilly and Company (1.27), greater than AstraZeneca PLC (0.89),
Company | Current Ratio | Market cap |
---|---|---|
1.32 | $172.97B | |
1.47 | $255.33B | |
0.31 | $355.39B | |
1.03 | $380.12B | |
1.24 | $112.12B | |
1.00 | $155.04B | |
1.27 | $737.03B | |
0.89 | $213.69B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gilead Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Gilead Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Gilead Sciences, Inc.'s Current Ratio?
How is the Current Ratio calculated for Gilead Sciences, Inc. (GILD)?
What is the highest Current Ratio for Gilead Sciences, Inc. (GILD)?
What is the 3-year average Current Ratio for Gilead Sciences, Inc. (GILD)?
What is the 5-year average Current Ratio for Gilead Sciences, Inc. (GILD)?
How does the current Current Ratio for Gilead Sciences, Inc. (GILD) compare to its historical average?